ReleaseWire Connect

There are a plethora of protein therapeutic products under the Phase III clinical trial development stage. The successful clinical trials of these products can revolutionize their usage and clinical applications. The most promising pipeline is for the monoclonal antibody products owing to the efficacy and specificity that they offer. These monoclonal antibodies are being researched for several disease applications. Primarily monoclonal antibodies are growing in the field of cancer due to their tumor specific targeting ability. Insulin products from Eli Lilly and Sanofi have also entered advanced phases of trials. Primarily aimed at haemophilia, these products can be expected to be of great therapeutics use for this blood disorder.

The ability of Biosimilars to act as growth engines by ensuring broader access to medicines and sustainability is helping biosimilars gain value in emerging economies. Countries such as India, China, Korea, Vietnam and Brazil are witnessing remarkable biosimilar uptake as compared to advanced economies. This surge can be attributed to local policies or the fragmented regulatory framework and "biosimilar" attitude of emerging nations. South Korea in particular, with plans to become a leading biosimilars player, is actively expanding its world-class clinical trials and production infrastructure, cultivating bio-specialized manpower, reinforcing global export capability, and building R&D, legal and system support strategies.

The global green building market is growing at a rapid speed because of the increasing awareness about large amount of greenhouse gas emissions by building sectors in the environment. The growth is accelerating as it has become a long term business opportunity for the builders. Homeowners and tenants are opting for green buildings more as green buildings are energy efficient and they are highly cost effective in the long run. The improved insulation techniques and green technologies help in reducing the energy consumption during cooling and heating of a building cutting down the building's GHG footprint in the environment. Green building works in favor of water conservation and waste recycling as well.

NIPT represents an untapped potential market of over US$ 400 Million in India. Interest in NIPT is so high that despite no official launches, there have been instances of patients sending their samples to be tested from foreign based NIPT players. Still, players have been wary of entering the untested market of Indian NIPT. Most of the apprehensions have been around the obstacles that they deem the market has. Our research reveals that despite its challenges, Indian NIPT market is raw with immense opportunities. If worked around intelligently, none of the barriers are too significant to overcome.

The growing realization of the benefits associated with Advance Wound Care products, the demand for such products is expected to escalate. AWC offers more benefits as compared to traditional wound management techniques. These benefits include increased comfort, less time for dressing changes, faster healing, and reduced complications of further infection.

Engineering plastics exhibits high dimensional stability, good heat and chemical resistance and high strength. Apart from this each type of engineering plastic has its own unique set of properties making them the material of choice in several applications. Due to this reason the application of engineering plastic is extensive and is growing at a fast pace. Global Engineering Plastic market is displaying vibrant signs of huge future potential. The market is experiencing rapid growth, which is expected to continue in the near future, mainly driven by ability of engineering plastics to replace metals in various end user industries.

According to a new research report by RNCOS entitled, "US Generic Drug Market Outlook 2018", the US represents the world's largest pharmaceutical markets with highest prescription sales. It is amongst the most attractive prescription drug markets and has caught the attention of several manufacturers globally, as evident from the launch of numerous generic equivalents of the branded products. Factors such as continuing patent expiration, increasing healthcare expenditure, revision of the Obamacare healthcare bill, rising disposable incomes, reduced prices of medications and rising ageing population, etc., have been driving the US Generics market, which accounts for 45% of the global Generics industry.

From microbots that scrape plaque from arteries to personal assistant robots that help care for patients, medical robots are transforming the face of healthcare.

The increasing inclination of the public towards the prepaid cards is encouraging more companies and banks to provide prepaid card services. Indian banks are now undertaking aggressive marketing and promotion activities to increase prepaid cards awareness in India. Banking and Non-banking players have embarked on lucrative promotional strategies to overcome the hurdle of very low consumer awareness.

With support from the Energy Department, private industry and the Department's national laboratories have already achieved significant advances in fuel cell and hydrogen technologies like reducing costs and improving performance. The US continues to be one of the world's largest and fastest growing markets for fuel cell and hydrogen technologies. With this flourishing demand US fuel Cell shipment is expected to grow at CAGR of 23%, says RNCOS in its latest research report.